Quality management system

Retrocausal Revolutionizes Manufacturing Process Management with Industry-First Generative AI LeanGPT™ offering

Retrieved on: 
Thursday, April 20, 2023

SEATTLE, April 20, 2023 (GLOBE NEWSWIRE) -- Retrocausal , a leading manufacturing process management platform provider, today announced the release of LeanGPT™, its proprietary foundation models specialized for the manufacturing domain.

Key Points: 
  • SEATTLE, April 20, 2023 (GLOBE NEWSWIRE) -- Retrocausal , a leading manufacturing process management platform provider, today announced the release of LeanGPT™, its proprietary foundation models specialized for the manufacturing domain.
  • In addition, it can be connected to an organization’s knowledge bases, including Continuous Improvement (CI) systems, Quality Management Systems (QMS), and Manufacturing Execution Systems (MES) systems, in a secure manner.
  • According to the US Bureau of Labor Statistics, Industrial Engineering is a $27B market in the United States alone.
  • “We trained Retrocausal's generative AI LeanGPT models on specialized knowledge needed for manufacturing,” said Dr. Zeeshan Zia , CEO of Retrocausal.

Latham BioPharm Group Expands Offering into Digital Health

Retrieved on: 
Wednesday, April 12, 2023

BALTIMORE, April 12, 2023 /PRNewswire/ -- Latham BioPharm Group (LBG), part of Sia Partners , is excited to announce the addition of a new capability centered around Digital Health Consulting.

Key Points: 
  • BALTIMORE, April 12, 2023 /PRNewswire/ -- Latham BioPharm Group (LBG), part of Sia Partners , is excited to announce the addition of a new capability centered around Digital Health Consulting.
  • Digital tools, such as new AI engines, the expanding functionalities of smart devices, and the sophistication of virtual reality, will continue to accelerate healthcare transformation.
  • The acquisition by Sia Partners, a global leader in digital transformation, has enabled LBG to expand its capabilities to support digital healthcare.
  • "Now with expanded capabilities in AI, data analysis, and digital transformation, as well as numerous experts working in digital healthcare product development, LBG is well positioned to help bring digital healthcare products to market and serve as a leader in the digital transformation of medicine."

Latham BioPharm Group Expands Offering into Digital Health

Retrieved on: 
Tuesday, April 11, 2023

BALTIMORE, April 11, 2023 /PRNewswire/ -- The Latham BioPharm Group (LBG), part of Sia Partners, is excited to announce the addition of a new capability centered around Digital Health Consulting.

Key Points: 
  • BALTIMORE, April 11, 2023 /PRNewswire/ -- The Latham BioPharm Group (LBG), part of Sia Partners, is excited to announce the addition of a new capability centered around Digital Health Consulting.
  • Digital tools such new AI engines, the expanding functionalities of smart devices, and the sophistication of virtual reality will continue to accelerate healthcare transformation.
  • With the acquisition by Sia Partners, a global leader in digital transformation, LBG has expanded its capabilities to support digital healthcare.
  • For more information about Latham BioPharm Group, please visit their website here .

Dot Compliance Launches First AI-Based ChatGPT Powered eQMS For Life Sciences

Retrieved on: 
Tuesday, April 4, 2023

PHOENIX, April 4, 2023 /PRNewswire/ -- Dot Compliance, a leading provider of eQMS compliance solutions for the life sciences sector, has introduced an industry-first, ready-to-use AI-Based electronic Quality Management System for life sciences, powered by an embedded generative and predictive artificial intelligence. The system deploys ChatGPT combined with proprietary algorithms to optimize quality processes, automate tasks and help professionals working in quality assurance to focus on what really matters while enhancing the compliance of their organizations.

Key Points: 
  • Primed to revolutionize quality management and compliance for the life sciences industry, Dot Compliance's ready-to-use generative and predictive AI automation increases efficiency and higher quality outcomes in compliance, documentation, and reporting.
  • PHOENIX, April 4, 2023 /PRNewswire/ -- Dot Compliance , a leading provider of eQMS compliance solutions for the life sciences sector, has introduced an industry-first, ready-to-use AI-Based electronic Quality Management System for life sciences, powered by an embedded generative and predictive artificial intelligence.
  • "There is a wealth of untapped potential for innovation in quality management regarding compliance, and Dot Compliance has shown leadership in this space.
  • The Dot Compliance Suite includes an extensive set of fully pre-validated ready to use eQMS processes.

Calibre Continues to Expand the New High-Grade Gold Discovery at Panteon North & Along the Multi-Kilometre VTEM Gold Corridor; Additional Drilling Intersects 17.45 g/t Gold Over 4.1 Metres Following Up on the December 2022 Intercept of 11.61 g/t Gold Over

Retrieved on: 
Tuesday, March 21, 2023

These new intercepts continue to demonstrate the potential of the multi-kilometre long structure identified by our 2022 VTEM geophysical survey released on December 8, 2022 (see news release here ).

Key Points: 
  • These new intercepts continue to demonstrate the potential of the multi-kilometre long structure identified by our 2022 VTEM geophysical survey released on December 8, 2022 (see news release here ).
  • Today’s results are located more than 2 kilometres north of Panteon North which has had numerous bonanza grade gold intercepts to-date as evidenced in our most recent press release here .
  • Prior to analysis, samples are prepared at Veritas' Managua facility and then shipped to its analytical facility in Vancouver, Canada.
  • For greater precision of high-grade material, samples assaying 10 g/t Au or higher are re-assayed by fire assay with gravimetric finish.

RAJANT RECEIVES FIFTH CONSECUTIVE YEAR ISO 9001:2015 RECERTIFICATION

Retrieved on: 
Tuesday, March 14, 2023

Morehead, Kentucky, March 14, 2023 (GLOBE NEWSWIRE) -- Rajant Corporation , the pioneer of Kinetic Mesh® wireless networks, has been recertified for the fifth consecutive year as ISO (International Organization for Standardization) 9001: 2015-compliant.

Key Points: 
  • Morehead, Kentucky, March 14, 2023 (GLOBE NEWSWIRE) -- Rajant Corporation , the pioneer of Kinetic Mesh® wireless networks, has been recertified for the fifth consecutive year as ISO (International Organization for Standardization) 9001: 2015-compliant.
  • The original ISO 9001:2015 Quality Management System (QMS) certification was achieved on March 7, 2019, when Rajant demonstrated compliance with the development, technical support, and manufacturing of secure network radios at its Morehead, Kentucky facility.
  • Scott Broughton, Executive Director, Kentucky Manufacturing Extension Partnership (KY-MEP) has worked with Rajant’s Morehead team since the original certification.
  • Mr. Boughton shares, “Congratulations to Rajant on its recent recertification of its Quality Management System to the ISO 9001 standard.

HealthRecon Connect Successfully Attains SOC 2® Type 2 Certification

Retrieved on: 
Friday, March 3, 2023

DALLAS, March 03, 2023 (GLOBE NEWSWIRE) -- HealthRecon Connect, a leading technology enabled revenue cycle management solutions provider to US Healthcare Providers, reaffirmed its commitment to maintaining high standards of service delivery and internal security controls by successfully completing the System and Organizational Controls SOC 2® Type 2 audit.

Key Points: 
  • DALLAS, March 03, 2023 (GLOBE NEWSWIRE) -- HealthRecon Connect, a leading technology enabled revenue cycle management solutions provider to US Healthcare Providers, reaffirmed its commitment to maintaining high standards of service delivery and internal security controls by successfully completing the System and Organizational Controls SOC 2® Type 2 audit.
  • A widely recognized auditing standard developed by the American Institute of Certified Public Accountants (AICPA), the SOC 2® audits assess the security, availability, processing integrity, confidentiality and privacy controls in service organizations against the AICPA’s Trust Services Criteria (TSC).
  • “Obtaining the SOC 2® certification reaffirms our commitment to providing our clientele and stakeholders the highest level of internal controls and security” – Denver Fernando, CEO of HealthRecon Connect.
  • The successful completion of the SOC 2® Type 2 certification complements the organization’s recent achievement of being awarded the SOC 2® Type 1 and SOC 1® Type 1 and 2 certifications, the ISO 9001:2015 (Quality Management Systems), ISO 27001:2013 (Information Security Management) and ISO 27701:2019 (Privacy Information Management Systems) certifications and the seal of Compliance from the Compliancy Group, the recognized third-party HIPAA compliance verification standard for healthcare professionals, vendors, and IT professionals across the healthcare industry.

ArisGlobal Signs Agreement to Acquire Amplexor Life Sciences, Creating the Most Comprehensive Regulatory SaaS Platform for the Industry

Retrieved on: 
Tuesday, February 28, 2023

MIAMI and NOVO MESTO, Slovenia, Feb. 28, 2023 /PRNewswire/ -- ArisGlobal, the leading provider of life sciences software designed to automate core drug development functions with its end-to-end technology platform LifeSphere® today announces the acquisition of Amplexor Life Sciences (LS), a global provider of regulatory, quality, and safety software solutions, serving and trusted by pharmaceutical, biotechnology, and medical device companies. 

Key Points: 
  • LifeSphere users are now gaining access to enhanced publishing and labeling capabilities; in addition to a robust Quality Management System (QMS) from Amplexor LS.
  • Amplexor LS's regulatory customers can now connect to even wider functionality through ArisGlobal's market leading LifeSphere platform including access to state-of-the-art Safety, Medical Affairs and Clinical solutions.
  • It also represents many years of industry expertise, software innovation, and customer excellence from ArisGlobal and Amplexor Life Sciences.
  • "The vision and objectives of ArisGlobal and Amplexor LS are aligned," shares Jim Hilferty, AVP and Head of Regulatory at ArisGlobal.

ArisGlobal Signs Agreement to Acquire Amplexor Life Sciences, Creating the Most Comprehensive Regulatory SaaS Platform for the Industry

Retrieved on: 
Tuesday, February 28, 2023

MIAMI and NOVO MESTO, Slovenia, Feb. 28, 2023 /PRNewswire/ -- ArisGlobal, the leading provider of life sciences software designed to automate core drug development functions with its end-to-end technology platform LifeSphere® today announces the acquisition of Amplexor Life Sciences (LS), a global provider of regulatory, quality, and safety software solutions, serving and trusted by pharmaceutical, biotechnology, and medical device companies. 

Key Points: 
  • LifeSphere users are now gaining access to enhanced publishing and labeling capabilities; in addition to a robust Quality Management System (QMS) from Amplexor LS.
  • Amplexor LS's regulatory customers can now connect to even wider functionality through ArisGlobal's market leading LifeSphere platform including access to state-of-the-art Safety, Medical Affairs and Clinical solutions.
  • It also represents many years of industry expertise, software innovation, and customer excellence from ArisGlobal and Amplexor Life Sciences.
  • "The vision and objectives of ArisGlobal and Amplexor LS are aligned," shares Jim Hilferty, AVP and Head of Regulatory at ArisGlobal.

Enzymit Receives ISO 9001 Quality Management System Certification for Sustainable Enzyme Development

Retrieved on: 
Tuesday, February 21, 2023

NESS ZIONA, Israel, Feb. 21, 2023 /PRNewswire/ -- Enzymit, a bioproduction platform company developing cell-free enzymatic manufacturing technology, today announced it has been awarded International Organization for Standardization (ISO) 9001:2015 certification for its design of novel enzymes and enzymatic processes.

Key Points: 
  • ISO 9001 is the world's most recognized Quality Management System (QMS) standard, helping to ensure organizations meet the needs of their customers and other stakeholders more effectively.
  • This certification recognizes Enzymit's commitment to quality management and ensuring customer satisfaction.
  • "Enzymit has made concerted efforts to ensure that our proprietary development and manufacturing processes conform with the highest industry standards," said Gideon Lapidoth, PhD, CEO of Enzymit.
  • To achieve ISO 9001 certification, Enzymit was required to fulfill a range of criteria.